Blog

FDA approves Anoro Ellipta to treat chronic obstructive pulmonary disease The U.S. Food and Drug Administration today approved Anoro Ellipta (umeclidinium and vilanterol inhalation powder)

Stiolto: New drug to treat COPD STIOLTO RESPIMAT (tiotropium bromide and olodaterol) (sti-OL-to– RES peh mat) Boehringer Ingelheim Approval date: May 21, 2015 What is

Breo: New drug to treat COPD: The U.S. Food and Drug Administration today approved Breo Ellipta (fluticasone furoate and vilanterol inhalation powder) for the long-term,

Opdivo (nivolumab) to treat patients with advanced (metastatic) squamous non-small cell lung cancer (NSCLC) The U.S. Food and Drug Administration today expanded the approved use

Millions of smokers may have undiagnosed COPD More than half of smokers with normal spirometry had some form of respiratory-related impairment associated with COPD, Dr.

Hookahs Do Not Filter Out Toxins FRIDAY, Feb. 20, 2015 (HealthDay News) — Contrary to what many people think, hookah water pipes do not filter

Endoscopic Retrograde Cholangiopancreatography (ERCP) Duodenoscopes: FDA Safety Communication – Design May Impede Effective Cleaning [Posted 02/19/2015] AUDIENCE: Gastroenterology, Surgery, Nursing, Risk Manager, Biomedical Engineering, Patient

Cytisine was superior to nicotine-replacement therapy for smoking cessation http://www.nejm.org/doi/full/10.1056/NEJMoa1407764#t=abstract

Obesity, diabetes, and the moving targets of healthy-years estimation Many studies have attempted to quantify the effect of obesity on death, fueling a sustained controversy